| 1 | [SID49670814] | Active | EC50 | 5.912 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | EC50 | 5.912 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 2 | [SID49670814] | Active | EC50 | 5.912 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | EC50 | 5.912 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 3 | [SID49670814] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 4 | [SID49670814] | Active | Potency | 15.8489 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 5 | [SID49670814] | Active | Potency | 15.8489 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 6 | [SID49670814] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 7 | [SID49670814] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 8 | [SID49670814] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 9 | [SID49670814] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 10 | [SID49670814] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 11 | [SID49670814] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 12 | [SID49670814] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID49670814] | Active | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID49670814] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 15 | [SID49670814] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 16 | [SID49670814] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 17 | [SID49670814] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 18 | [SID49670814] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 19 | [SID49670814] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 20 | [SID49670814] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 21 | [SID49670814] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 22 | [SID49670814] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID49670814] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID49670814] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID49670814] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID49670814] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 27 | [SID49670814] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 28 | [SID49670814] | Inactive | Potency | 14.6892 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | 14.6892 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID49670814] | Inactive | EC50 | 92.489 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | EC50 | 92.489 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 30 | [SID49670814] | Inactive | EC50 | 92.489 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | EC50 | 92.489 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 31 | [SID49670814] | Inactive | EC50 | 92.489 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | EC50 | 92.489 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 32 | [SID49670814] | Inactive | EC50 | 92.489 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | EC50 | 92.489 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 33 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 34 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 35 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 36 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 37 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 38 | [SID49670814] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) [AID2445, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR) | | AID | 2445 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 39 | [SID49670814] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 40 | [SID49670814] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 41 | [SID49670814] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 42 | [SID49670814] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 43 | [SID49670814] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 44 | [SID49670814] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 45 | [SID49670814] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 46 | [SID49670814] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 47 | [SID49670814] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 48 | [SID49670814] | Inactive | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 49 | [SID49670814] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay. [AID1817, Type: confirmatory] | plectin 1 [Homo sapiens] [gi:40849930] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay. | | AID | 1817 | | BioAssay type | confirmatory | | Target | plectin 1 [Homo sapiens] [gi:40849930] | | PubMed | | | Data Table |  |
|
| 50 | [SID49670814] | Inactive | Potency | | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49670814 | | CID | 17387246 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|